Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Lipids Health Dis ; 10: 226, 2011 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-22142357

RESUMEN

BACKGROUND: diabetes is a serious health problem and a source of risk for numerous severe complications such as obesity and hypertension. Treatment of diabetes and its related diseases can be achieved by inhibiting key digestives enzymes-related to starch digestion secreted by pancreas. METHODS: The formulation omega-3 with fenugreek terpenenes was administrated to surviving diabetic rats. The inhibitory effects of this oil on rat pancreas α-amylase and maltase and plasma angiotensin-converting enzyme (ACE) were determined. RESULTS: the findings revealed that administration of formulation omega-3 with fenugreek terpenenes (Om3/terp) considerably inhibited key enzymes-related to diabetes such as α-amylase activity by 46 and 52% and maltase activity by 37 and 35% respectively in pancreas and plasma. Moreover, the findings revealed that this supplement helped protect the ß-Cells of the rats from death and damage. Interestingly, the formulation Om3/terp modulated key enzyme related to hypertension such as ACE by 37% in plasma and kidney. Moreover administration of fenugreek essential oil to surviving diabetic rats improved starch and glucose oral tolerance additively. Furthermore, the Om3/terp also decreased significantly the glucose, triglyceride (TG) and total-cholesterol (TC) and LDL-cholesterol (LDL-C) rates in the plasma and liver of diabetic rats and increased the HDL-Cholesterol (HDL-Ch) level, which helped maintain the homeostasis of blood lipid. CONCLUSION: overall, the findings of the current study indicate that this formulation Om3/terp exhibit attractive properties and can, therefore, be considered for future application in the development of anti-diabetic, anti-hypertensive and hypolipidemic foods.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Ácidos Grasos Omega-3/farmacología , Hipertensión/tratamiento farmacológico , Aceites de Plantas/farmacología , Terpenos/farmacología , Trigonella/química , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Glucemia , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/complicaciones , Combinación de Medicamentos , Ácidos Grasos Omega-3/farmacocinética , Inhibidores de Glicósido Hidrolasas , Hipertensión/sangre , Hipertensión/etiología , Hipoglucemiantes/farmacología , Lípidos/sangre , Masculino , Páncreas/efectos de los fármacos , Páncreas/enzimología , Páncreas/patología , Peptidil-Dipeptidasa A/sangre , Ratas , Ratas Wistar , Semillas/química , alfa-Amilasas/antagonistas & inhibidores , alfa-Amilasas/sangre , alfa-Glucosidasas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA